The role of pacing in rhythm control and management of atrial fibrillation

Journal of Interventional Cardiac Electrophysiology

Volumn 18, Issue 2, 2007, Pages 159-186

  Silberbauer, John ^a   Sulke, Neil ^a  

^a EASTBOURNE DISTRICT GENERAL HOSPITAL   (United Kingdom)

Author keywords

Antitachycardia pacing; Atrial fibrillation; Atrial pacing; Clinical trials; Dual chamber pacing; Pacemaker algorithm; Ventricular pacing

Indexed keywords

ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; CATHETER ABLATION; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART RHYTHM; HEART VENTRICLE PACING; HUMAN; PRIORITY JOURNAL; REVIEW; SUPRAVENTRICULAR TACHYCARDIA;

ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HUMANS; PACEMAKER, ARTIFICIAL;

EID: 34249720165     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-007-9087-z     Document Type: Review

References (137)

1. Go, A. S., Hylek, E. M., Philips, K. A., Chang, Y., Henault, L. E., & Selby, J. V., et al. (2001). Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Journal of the American Medical Association, 285, 2370-2375.
2. Veasey, R., Silberbauer, J., Vrahimides, J., Taggu, W., Paul, V., & Sulke, N. (2006). Do symptoms predict atrial fibrillation episodes in patients with PAF? Journal of the American College of Cardiology, 42(4), 34A.
3. Kannel, W. B., Abbot, R. D., Savage, D. D., & McNamara, P. M. (1982). Epidemiologic features of chronic atrial fibrillation: The Framingham study. New England Journal of Medicine, 306, 1018-1022.
4. Atrial Fibrillation Investigators. (1994). Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomised controlled trials. Archives of Internal Medicine, 154, 1449-1457.
5. Benjamin, E. J., Wolf, P. A., D'Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998). Impact of atrial fibrillation on the risk of death: The Framingham heart study. Circulation, 98, 946-952.
6. Fuchs, V. R. (1999). Health care for the elderly: How much? Who will pay for it? Health Affairs, 18, 11-21.
7. Batljan, I., & Legergren, M. (2004). Inpatient/outpatient health care costs and remaining years of life - Effect of decreasing mortality on future acute health care demand. Social Science & Medicine, 59, 2459-2466.
8. Van Gelder, I., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingm, T., et al. (2002). A comparison of rate and rhythm control in patients with recurrent persistent atrial fibrillation. New England Journal of Medicine, 347, 1834-1840.
9. Wyse, D. G. (2002). For the AFFIRM Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation. New England Journal of Medicine, 347, 1825-1833.
10. Chen, M. S., Marrouche, N. F., Khaykin, Y., Gillinov, A. M., Wazni, O., Martin, D. O., et al. (2002). Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. Journal of the American College of Cardiology, 43, 1004-1009.
11. Haissaguerre, M., Jais, P., Shah, D. C., Garrigue, S., Takahashi, A., Lavergne, T., et al. (2000). Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation, 101, 1409-1417.
12. Haissaguerre, M., Jais, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., et al. (1998). Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. New England Journal of Medicine, 339, 659-666.
13. Pappone, C., Rosanio, S., Augello, G., Gallus, G., Vicedomini, G., Mazzone, J. W., et al. (2003). Mortality, morbidity and quality of life after circumferential pulmonary vein ablation for atrial fibrillation. Journal of the American College of Cardiology, 42, 185-197.
14. Oral, H., Knight, B. P., Tada, H., Özaydin, M., Chugh, A., Hassan, S., et al. (2002). Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation, 105, 1077-1081.
15. Natale, A., Pisano, E., Shewchik, J., Bash, D., Fanelli, R., Potenza, D., et al. (2000). First human experience with pulmonary vein isolation using a through-the-balloon circumferential ultrasound ablation system for recurrent atrial fibrillation. Circulation, 102, 1879-1882.
16. Lamas, G. A., Ellenbogen, K. A., with the assistance of Hennekens, C. H., & Montanez, A. (2004). Evidence base for pacemaker mode selection. From physiology to randomised trials. Circulation, 109, 443-451.
17. Samet, P., Castillo, C., & Bernstein, W. H. (1966). Hemodynamic sequelae of atrial ventricular and sequential atrioventricular pacing in cardiac patients. American Heart Journal, 72, 725-729.
18. Rahimtoola, S. H., Ehsani, A., Sinno, M. Z., Loeb, H. S., Rosen, K. M., & Gunnar, R. M. (1975). Left atrial transport in myocardial infarction: Importance of its booster pump function. American Journal of Medicine, 59, 686-694.
19. Boucher, C. A., Pohost, G. M., Okada, R. D., Levine, F. H., Strauss, H. W., & Harthorne, J. W. (1983). Effect of ventricular pacing on left ventricular function assessed by radionuclide angiography. American Heart Journal, 106, 1105-1111.
20. Hoeschen, R. J., Reimold, S. C., Lee, R. T., Plappert, T. J., & Lamas, G. A. (1991). The effect of posture on the response to atrioventricular synchronous pacing in patients with underlying cardiovascular disease. Pacing and Clinical Electrophysiology, 14, 756-759.
21. Karlof, I. (1975). Hemodynamic effects of atrial triggered versus fixed rate pacing at rest and during exercise in complete heart block. Acta Medica Scandinavica, 197, 195-206.
22. Ravelli, F., & Allessie, M. (1997). Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation, 96, 1686-1695.
23. Nielsen, J. C., Pedersen, A. K., Mortensen, P. T., & Andersen, H. R. (1999). Programming a fixed long atrioventricular delay is not effective in preventing ventricular pacing in patients with sick sinus syndrome. Europace, 1, 113-120.
24. Han, J., Millet, D., Chizzonitti, B., & Moe, G. K. (1996). Temporal dispersion of recovery of excitability in atrium and ventricle as a function of heart rate. American Heart Journal, 71, 481-487.
25. Dimmer, C., Tavernier, R., Gjorgov, N., Van Nooten, G., Clement, D. L., & Jordaens, L. (1998). Variations of autonomic tone preceding onset of atrial fibrillationafter coronary bypass grafting. American Journal of Cardiology, 82, 22-25.
26. Haissaguerre, M., Jais, P., Takahashi, A., Hocini, M., Quiniou, G., Garrigue, S., et al. (1998). Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. New England Journal of Medicine, 339, 659-666.
27. Hill, M., Hammill, S., & Mehra, R. (1995). Onset and termination of spontaneous episodes of atrial fibrillation. Pacing and Clinical Electrophysiology, 18, 891.
28. Coumel, P. (1996). Autonomic influences in atrial tachyarrhythmias. Journal of Cardiovascular Electrophysiology, 7, 999-1007.
29. Lamas, G. A., Pashos, C. L., Normand, S. L. T., & McNeil, B. (1995). Permanent pacemaker selection and subsequent survival in elderly medicare pacemaker recipients. Circulation, 91, 1063-1069.
30. Jahangir, A., Shen, W. K., Neubauer, S. A., Ballard, D. J., Hammill, S. C., Hodge, D. O., et al. (1999). Relation between mode of pacing and long-term survival in the very elderly. Journal of the American College of Cardiology, 33, 1208-1216.
31. Lamas, G. A. (1997). Pacemaker mode selection and survival: A plea to apply the principles of evidence based medicine to cardiac pacing practice. Heart, 78, 218-220.
32. Connolly, S. J., Kerr, C., Gent, M., & Yusuf, S. (1996). Dual-chamber versus ventricular pacing: Critical appraisal of current data. Circulation, 94, 578-583.
33. Wharton, J. M., Sorrentino, R. A., Campbell, P., Gonzalez-Zuelgaray, L., Keating, E., & Curtis, A., et al. (1996). Effect of pacing modality on atrial tachyarrhythmia recurrence in the tachycardia-bradycardia syndrome: Preliminary results of the pacemaker atrial tachycardia trial (Abstr). Circulation, 98, I-494.
34. 3) study investigators. (2000). Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. Circulation, 102, 736-741.
35. Mattioli, A. V., Vivoli, D., & Mattioli, G. (1998). Influence of pacing modalities on the incidence of atrial fibrillationin patients without prior atrial fibrillation. European Heart Journal, 19, 282-286.
36. Connolly, S. J., Kerr, C., Gent, M., Roberts, R. S., Yusuf, S., Gillis, A. M., et al. (2000). Effects of physiologic versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. New England Journal of Medicine, 342, 1385-1391.
37. Kerr, C. R., Connolly, S. J., Abdollah, H., Roberts, R. S., Gent, M., Yusuf, S., et al. (2004). Canadian trial of physiological pacing: Effects of physiological pacing during long-term follow-up. Circulation, 109, 357-362.
38. Lamas, G. A., Lee, K. L., Sweeney, M. O., Silverman, R., Leon, A., Yee, R., et al. (2002). Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. New England Journal of Medicine, 346, 1854-1862.
39. Toff, W. D., Camm, A. J., & Skehan, J. D. (2005). Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. New England Journal of Medicine, 353, 145-155.
40. Skanes, A. C., Krahn, D. A., Yee, R., Klein, G. J., Connolly, S. J., Kerr, C. R., et al. (2001). Progression to chronic atrial fibrillation after pacing: The Canadian trial of physiologic pacing. Journal of the American College of Cardiology, 38, 167-172.
41. Lamas, G. A., Orav, E. J., Stambler, B. S., Ellenbogen, K. A., Sgarbossa, E.B., Stephen Huang, S. K., et al. (1998). Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. New England Journal of Medicine, 338, 1097-1104.
42. Stambler, B. S., Ellenbogen, K. A., Orav, E. J., Sgarbossa, E.B., Mark Estes, N. A., Rizo-Patron, C., et al. (2003). Predictors and clinical impact of atrial fibrillation after pacemaker implantation in elderly patients treated with dual chamber versus ventricular pacing. Pacing and Clinical Electrophysiology, 26, 2000-2007.
43. Andersen, H. R., Thuesen, L., Bagger, J. P., Vesterlund, T., & Thomsen, P. E. (1994). Prospective randomised trial of atrial versus ventricular pacing in sick sinus syndrome. Lancet, 344, 1523-1528.
44. Andersen, H. R., Nielsen, J. C., Thomsen, P. E. B., Thuesen, L., Mortensen, P. T., Vesterlund, T., et al. (1997). Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick sinus syndrome. Lancet, 350, 1210-1216.
45. Nielsen, J. C., Henning, R. A., Thomsen, P. E. B., Thuesen, L., Mortensen, P. T., Vesterlund, T., et al. (1998). Heart failure and echocardiographic changes during long-term follow-up of patients with sick sinus syndrome randomized to single-chamber atrial or ventricular pacing. Circulation, 97, 987-995.
46. Healey, J. S., Toff, W. D., Lamas, G. A., Andersen, H. R., Thorpe, K. E., Ellenbogen, K. A., et al. (2006). Cardiovascular outcomes with dual-chamber pacing compared to ventricular pacing: A meta-analysis of randomized trials, using individual patient data. Circulation, 114, 11-17.
47. Link, M. A., Hellkamp, A. S., Estes, N. A. M., Orav, E. J., Ellenbogen, K. A., Ibrahim, B., et al. (2004). High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the mode selection trial (MOST). Journal of the American College of Cardiology, 43, 2066-2071.
48. Sweeney, M. O., Hellkamp, A. S., Ellenbogen, K. A., Greenspon, A. J., Freedman, R. A., Lee, K. L., et al. (2003). Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation, 107, 2932-2937.
49. Nielsen, J. C., Kristensen, L., Andersen, H. R., Mortensen, P. T., Pedersen, O. L., & Pedersen, A. K. (2003). A randomised comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome. Journal of the American College of Cardiology, 42, 614-623.
50. Kristensen, L., Nielsen, J. C., Mortensen, P. T., Pedersen, O. L., Pedersen, A. K., & Andersen, H. R. (2004). Incidence of atrial fibrillation and thromboembolism in a randomised trial of atrial versus dual chamber pacing in 177 patients with sick sinus syndrome. Heart, 90, 661-666.
51. Andersen, R. H., Svendsen, J. H., on behalf of the DANPACE Investigators. (2001). The Danish multicenter randomized study on atrial inhibited versus dual-chamber pacing in sick sinus syndrome (The DANPACE Study). Heart Drug, 1, 67-70.
52. Blanc, J.-J., De Roy, L., Mansourati, J., Poezevara, Y., Marcon, J. -L., Wolfgang, S., et al. (2004). Atrial pacing for prevention of atrial fibrillation: Assessment of simultaneously implemented algorithms. Europace, 6, 371-379.
53. Lewalter, T., Yang, A., Pfeiffer, D., Ruiter, J., Schnitzler, G., Markert, T., et al. (2006). Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: Results from the VIP registry. Pacing and Clinical Electrophysiology, 29, 124-134.
54. Silberbauer, J., Freemantle, N., Arya, A., & Sulke, N. (2006). A meta-analysis of the AFT and PAFS study to determine the effect of right ventricular pacing on paroxysmal atrial fibrillation. European Heart Journal, 27(Abstract Suppl), 614-615.
55. Nielsen, J. C., Pedersen, A. K., Mortensen, P. T., & Andersen, H. R. (1999). Programming a fixed long atrioventricular delay is not effective in preventing ventricular pacing with sick sinus syndrome. Europace, 1, 113-120.
56. Sweeney, M. O., Ellenbogen, K. A., Casavant, D., Betzold, R., Sheldon, T., Tang, F., et al. (2005). Multicenter, prospective, randomised safety and efficacy study of a new atrial-based managed ventricular pacing mode (MVP) in dual chamber ICDs. Journal of Cardiovascular Electrophysiology, 16(8), 811-817.
57. Pollak, W. M., Simmons, J. D., Interian, A., Castellanos, A., Myerburg, R. J., Mitrani, R. D., et al. (2003). Pacemaker diagnostics: A critical appraisal of current technology. Pacing and Clinical Electrophysiology, 26, 76-98.
58. Kantharia, B. K., Wilbur, S. L., Padder, F. A., Pennington, J. C. III, Samuels, F. L., Movsowitz, C. M., et al. (2001). Effect of different location of atrial lead position on nearfiefd and farfield electrograms in dual chanber pacemaker-defibrilators. Journal of Interventional Cardiac Electrophysiology, 5, 59-66.
59. Wolpert, C., Jung, W., Scholl, C., Spehl, S., Cyran, J., & Luderitz, B. (1998). Electrical proarrhythmia; induction of inappropriate atrial therapies due to far-field R wave oversensing in a new dual chamber defibrillator. Journal of Cardiovascular Electrophysiology, 9, 859-863.
60. Frohlig, G., Helwani, Z., Kusch, O., Berg, M., & Schieffer, H. (1999). Bipolar ventricular far-field signals in the atrium. Pacing and Clinical Electrophysiology, 22, 1604-1613.
61. Brouwer, J., Nagelkerke, D., den Heijer, P., Ruiter, J. H., Mulder, H., Begemann, M. J., et al. (1997). Analysis of atrial sensed far-field ventricular signals: A reassessment. Pacing and Clinical Electrophysiology, 20, 916-922.
62. Silberbauer, J., Arya, A., Freemantle, N., Paul, V., Lloyd, G., Patel, N., et al. (2006). How accurate are beat to beat holters in implantable devices? Heart Rhythm, 3(1S), 126, May.
63. Inama, G., Santini, M., Padeletti, L., Boriani, G., Botto, G., Capucci, A., et al. (2004). Far-field R wave oversensing in dual chamber pacemakers designed for atrial arrhythmia management: Effect of pacing site and lead tip to ring distance. Pacing and Clinical Electrophysiology, 27, 1221-1230.
64. Nowak, B., Kracker, S., Rippin, G., Horstick, G., Vincent, A., Geil, S., et al. (2001). Effect of atrial blanking time on the detection of atrial fibrillation in dual chamber pacemakers. Pacing and Clinical Electrophysiology, 24, 496-499.
65. Leung, S., Lau, C., Lam, C., Tse, H. -F., Tang, M. -O., Chung, F., et al. (1998). Programmed atrial sensitivity: A critical determinant in atrial fibrillation detection and optimal mode switching. Pacing and Clinical Electrophysiology, 21, 2214-2219.
66. Ellenbogen, K., Mond, H., Wood, M., & Barold, S. (1997). Failure of automatic mode switching: Recognition and management. Pacing and Clinical Electrophysiology, 20, 268-275.
67. Lam, C., Lau, C., Leung, S., Tse, H.-F., Lee, K. L. F., Chan, W. K., et al. (1999). Improved efficacy of mode switching during atrial fibrillation using automatic atrial sensitivity adjustment. Pacing and Clinical Electrophysiology, 22, 17-25.
68. Israel, C. W. (2002). Analysis of mode switching algorithms in dual chamber pacemakers. Pacing and Clinical Electrophysiology, 25, 380-393.
69. Defaye, P., Dournaux, F., & Mouton, E. (1998). Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: The AIDA study. Pacing and Clinical Electrophysiology, 21, 250-255.
70. Lee, M. A., Weachter, R., Pollak, S., Kremers, M. S., Naik, A. M., Silverman, R., et al. (2003). The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency. Results of a randomised trial in patients with bradycardia and atrial tachyarrhythmias. Journal of the American College of Cardiology, 41, 1926-1932.
71. Israel, C. W., Hügl, B., Unterberg, C., Lawo, T., Kennis, I., Hettrick, D., et al. (2001). Pace-termination and pacing for prevention of atrial tachyarrhythmias: Results from a multicenter study with an implantable device for atrial therapy. Journal of Cardiovascular Electrophysiology, 12, 1121-1128.
72. Purerfellner, H., Gillis, A., Holbrook, R., & Hettrick, D. (2004). Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies. Pacing and Clinical Electrophysiology, 27, 983-992.
73. de Voogt, W. G., van Hemel, N. M., van de Bos, A. A., Koistinen, J., & Fast, J. (2006). Verification of pacemaker automatic mode switching for the detection of atrial fibrillation and atrial tachycardia with Holter recording. Europace, 8, 950-961.
74. Padeletti, L., Pürerfellner, H., Adler, S. W., Waller, T. J., Harvey, M., Horvitz, L., et al. (2003). Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. Journal of Cardiovascular Electrophysiology, 14, 1189-1195.
75. Passman, R. S., Weinberg, K. M., Freher, M., Schaechter, A., Goldberger, J., & Kadish, A. (2004). Accuracy of mode switching for the detection of atrial tachyarrhythmias. Journal of Cardiovascular Electrophysiology, 15, 773-777.
76. Ricci, R., Puglisi, A., Azzolini, P., Spampinato, A., Pignalberi, C, Belloci, F., et al. (1996). Reliability of a new algorithm for automatic mode switching from DDDR to DDIR pacing mode in sinus node disease patients with chronotropic incompetence and paroxysmal atrial fibrillation. Pacing and Clinical Electrophysiology, 19, 1719-1723.
77. Israel, C. W., Grönefeld, G., Ehrlich, J. R., Li, Y., & Hohnloser, S. (2004). Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device. Journal of the American College of Cardiology, 43, 47-52.
78. Grönefeld, G., Lilienthal, J., Kuck, K. H., & Hohnloser, S. H. (2003). Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation: Results from a prospective randomised study. European Heart Journal, 24, 1430-1436.
79. Gillis, A. M., & Rose, M. S. (2000). Temporal patterns of paroxysmal atrial fibrillation following DDDR pacemaker implantation. American Journal of Cardiology, 85, 1445-1450.
80. Kaemmerer, W. F., Rose, S., & Mehra, R. (2001). Distribution of patients' paroxysmal atrial tachyarrhythmia episodes: Implications for detection of treatment efficacy. Journal of Cardiovascular Electrophysiology, 12, 121-130.
81. Shehadeh, L. A., Liebovitch, L. S., & Wood, M. A. (2002). Temporal patterns of atrial arrhythmia recurrences in patients with implantable defibrillators. Implications for assessing antiarrhythmic therapies. Journal of Cardiovascular Electrophysiology, 13, 303-309.
82. Ricci, R., Santini, M., Padeletti, L., Boriani, G., Capucci, A., Botto, G., et al. (2004). Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers. Journal of Cardiovascular Electrophysiology, 15, 44-51.
83. Glotzer, T. V., Hellcamp, A. S., Zimmermann, J., Sweeney, M.O., Yee, R., Marinchak, R., et al. (2003). Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: Report of the atrial diagnostics ancillary substudy of the mode selection trial. Circulation, 107, 1614-1619.
84. Glotzer, T. V., Daoud, E. G., Wyse, D. G., Singer, D. E., Holbrook, R., Pruett, K., et al. (2006). Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: The TRENDS study. Journal of Interventional Cardiac Electrophysiology, 15, 9-14.
85. Hohnloser, H., Capucci, A., Fain, E., Gold, M. R., Van Gelder, I. C., & Healey, J., et al. (2006). ASymptomatic atrial fibrillation and stroke evaluation in pacemaker patients and the atrial fibrillation reduction atrial pacing trial. American Heart Journal, 152, 442-447.
86. Fauchier, L., Briand, F., Soto, F. X., Quennelle, F., Levy, J., Darmon, J. P., et al. (2003). Management of atrial tachyarrhythmias: Benefits of pacemaker diagnostics. Pacing and Clinical Electrophysiology, 26(Pt II), 233-238.
87. Marshall, A. J., Nash, A., Owen, P. A. R., Todd, D., & Jones, D. (2004). Pacemaker diagnostics to determine treatment and outcome in sick sinus syndrome with paroxysmal atrial fibrillation. Pacing and Clinical Electrophysiology, 27, 1130-1135.
88. Purerfellner, H., Aichinger, J., Martinek, M., Nesser, H. J., Ziegler, P., Koehler, J., et al. (2004). Quantification of atrial tachyarrhythmia burden with an implantable pacemaker before and after pulmonary vein isolation. Pacing and Clinical Electrophysiology, 27, 1277-1283.
89. Montenero, A. S., Quayyum, A., Franciosa, P., Mangiameli, D., Antonelli, A., Barbieri, L., et al. (2004). Implantable loop recorders: A novel method to judge patient perception of atrial fibrillation. Preliminary results from a pilot study. Journal of Interventional Cardiac Electrophysiology, 10, 211-220.
90. Hoffmann, E., Sulke, N., Edvardsson, N., Ruiter, J., Lewalter, T., Capucci, A., et al. (2006). New insights into the initiation of atrial fibrillation. A detailed intra- and interindividual analysis of the spontaneous onsets of atrial fibrillation using new diagnostic pacemaker features. Circulation, 113, 1933-1941.
91. Gillis, A. M., Wyse, D. G., Connoly, S. J., Dubuc, M., Philippon, F., Yee, R., et al. (1999). Atrial pacing peri-ablation for prevention of paroxysmal atrial fibrillation. Circulation, 99, 2553-2558.
92. Mont, L., Sambola, A., Brugada, J., Vaccal, M., Marrugat, J., Elosna, R., et al. (2002). Long-lasting sport practice and lone atrial fibrillation. European Heart Journal, 23, 477-482.
93. Lam, C. T. F., Lau, C.-P., Leung, S.-K., Tse, H. -F., Lee, K. L. F., Tang, M. O., et al. (2000). Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation. Europace, 2, 286-291.
94. Ricci, R., Santini, M., Puglisi, A., Azzolini, P., Capucci, A., Pignalberi, C., et al. (2001). Impact of consistent atrial pacing algorithm on premature atrial complexe number and paroxysmal atrial fibrillation recurrences in brady-tachy syndrome: A randomized prospective cross over study. Journal of Interventional Cardiac Electrophysiology, 5, 33-44.
95. Puglisi, A., Altamura, G., Capestro, F., Castaldi, B., Critelli, G., Favale, S., et al. (2003). Impact of closed-loop stimulation, overdrive pacing, DDDR mode on atrial tachyarrhythmia burden in brady-tachy syndrome. European Heart Journal, 24, 1952-1961.
96. Carlson, M. D., Ip, J., Messenger, J., Beau, S., Kalbfleisch, S., Gervais, P., et al. (2003). A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the atrial dynamic overdrive pacing trial (ADOPT). Journal of the American College of Cardiology, 42, 627-633.
97. Israel, C. W., Grönefeld, G., Ehrlich, J. R., Li, Y., & Hohnloser, S. H. (2003). Prevention of immediate reinitiation of atrial tachyarrhythmias by high-rate overdrive pacing: Results from a prospective randomised trial. Journal of Cardiovascular Electrophysiology, 14, 954-959.
98. Wiberg, S., Lönnerholm, S., Jensen, S. M., Blomström, P., Ringqvist, I., & Blomstrom-Lundqvist, C. (2003). Effect of right atrial overdrive pacing in the prevention of symptomatic paroxysmal atrial fibrillation: A multicenter randomized study, the PAF-PACE study. Pacing and Clinical Electrophysiology, 26, 1841-1848.
99. Schuchert, A., Bub, E., Braun, M., Rebeski, H.-P., Kroll, W., Mortensen, K., et al. (2004). Comparison of triggered versus triggered and continuous atrial overdrive pacing on AF burden in pacemaker patients with paroxysmal atrial fibrillation. Heart Rhythm, 1(1S), 866, (abstract).
100. Gold, M., & Hoffmann, E. (2006). The impact of atrial prevention pacing on AF burden: Primary results of the study for atrial fibrillation reduction (SAFARI) trial. Europace, 8(S1), 222-223.
101. Funck, R. C., Adamec, R., Lurje, L., Capucci, A., Ritter, P., Shekan, D., et al. (2000). Atrial overdriving is beneficial in patients with atrial arrhythmias: First results of the PROVE study. Pacing and Clinical Electrophysiology, 23, 1891-1893.
102. Beinhauer, A., Vock, P., Nobis, H., Unger, T., Hartkainon, J., & Hedman, A. (2001). DAO algorithm reduced AF burden by 39% in patients in ADOPT-ALL trial. Europace, 3(Pt4), 635.
103. Stephenson, E. A., Casavant, D., Tuzi, J., Alexander, M. E., Law, I., Serwer, G., et al. (2003). Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. American Journal of Cardiology, 92, 871-876.
104. Gillis, A. M., Unterberg-Buchwald, C., Schmidinger, H., Massimo, S., Wolfe, K., Kavaney, D. J., et al. (2002). Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. Journal of the American College of Cardiology, 40(9), 1653-1659.
105. Padeletti, L., Santini, M., Boriani, G., Botto, G., Gulizia, M., Molon, G., et al. (2005). Long-term reduction of atrial tachyarrhythmia recurrences in patients paced for bradycardia-tachycardia syndrome. Heart Rhythm, 2, 1047-1057.
106. Mitchell, A. R., Spurrell, P. A., Cheatle, L., & Sulke, N. (2002). Effect of atrial antitachycardia pacing treatments in patients with an atrial defibrillator: Randomised study comparing subthreshold and nominal pacing outputs. Heart, 87(5), 433-437.
107. Adler, S. W., Wolpert, C., Warman, E. N., Musley, S. K., Koehler, J. L., Euler, D. E., et al. (2001). Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter-defibrillator. Circulation, 104(8), 887-892.
108. Gold, M. R., Sulke, N., Schwartzman, D. S., Mehra, R., & Euler, D. E. (2001). Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. Journal of Cardiovascular Electrophysiology, 12, 1247-1253.
109. Strickberger, S. A., Ip, J., Saksena, S., Curry, K., Bahnson, T. D., & Ziegler, P. D. (2005). Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm, 2, 125-131.
110. Gillis, A. M., Koehler, J., Morck, M., Mehra, R., & Hettrick, D. (2005). High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation. Heart Rhythm, 2, 791-796.
111. Prakash, A., Saksena, S., Hill, M., Krol, R. B., Munsif, A. N., Giorgberiolze, I., et al. (1997). Acute effects of dual-site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation. Journal of the American College of Cardiology, 29, 1007-1014.
112. Daubert, C., Mabo, P. H., Berder, V., Gras, D., & Leclerq, C. (1994). Atrial tachyarrhythmias associated with high degree interatrial conduction block: Prevention by permanent atrial resynchronisation. European Journal of Cardiac Pacing and Electrophysiology, 1, 35-44.
113. Matsumoto, K., Ishikawa, T., Sumita, S., Matsushita, K., Kawasaki, N., Kobayashi, T., et al. (2005). Beneficial effects of biatrial pacing on cardiac function in patients with bradycardia-tachycardia syndrome. Circulation, 69, 831-836.
114. Doi, A., Takagi, M., Toda, I., Yoshiyama, M., Takeuchi, K., & Yoshikawa, J. (2004). Acute haemodynamic effects of biatrial atrioventricular sequential pacing: Comparison with single atrial atrioventricular sequential pacing. Heart, 90, 411-418.
115. Saksena, S., Prakash, A., Hill, M., Krol, R. B., Munsif, A. N., Mathew, P. P., et al. (1996). Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. Journal of the American College of Cardiology, 28, 687-694.
116. Delfaut, P., Saksena, S., Prakash, A., & Krol, R. B. (1998). Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention. Journal of the American College of Cardiology, 32, 1900-1908.
117. Saksena, S., Prakash, A., Ziegler, P., Hummel, J. D., Friedman, P., Plumb, V., et al. (2002). Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. Journal of the American College of Cardiology, 40, 1140-1150.
118. Lau, C.-P., Tse, H.-F., Yu, C.-M., Teo, W.-S., Kam, R., Ng, K.-S., et al. (2001). Dual-site atrial pacing for atrial fibrillation in patients without bradycardia. American Journal of Cardiology, 88, 371-375.
119. Padeletti, L., Pieragnoli, P., Ciapetti, C., Colella, A., Musilli, N., Porciani, M. C., et al. (2001). Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. American Heart Journal, 142(6), 1047-1055.
120. de Voogt, W. (2006). Low atrial septal pacing in pacemaker patients, chapter 7. ISBN-10: 90-76241-14-17.
121. Bailin, S. J., Adler, S., & Giudici, M. (2001). Prevention of chronic atrial fibrillation by pacing in the region of Bachmann's bundle: Results of a multicenter randomised trial. Journal of Cardiovascular Electrophysiology, 12(8), 912-917.
122. Hermida, J.-S., Kubala, M., Lescure, F.-X., Delonca, J., Clerc, J., Otmani, A., et al. (2004). Atrial septal pacing to prevent atrial fibrillation in patients with sinus node dysfunction: Results of a randomized controlled study. American Heart Journal, 148, 312-317.
123. Kale, M., & Bennett, D. H. (2003). Pacemaker prevention therapies for the control of drug-refractory paroxysmal atrial fibrillation. Europace, 5, 123-131.
124. Mirza, I., James, S., & Holt, P. (2002). Biatrial pacing for paroxysmal atrial fibrillation. A randomised prospective study into the suppression of paroxysmal atrial fibrillation using biatrial pacing. Journal of the American College of Cardiology, 40, 457-463.
125. Mabo, P., Daubert, J. C., Bouhour, A. (1999). Biatrial synchronous pacing for atrial arrhythmia prevention: The SYNBIAPACE study. Pacing and Clinical Electrophysiology, 22, 755.
126. Levy, T., Walker, S., Rex, S., Rochelle, J., & Paul, V. (2001). No incremental benefit of multisite atrial pacing compared with right atrial pacing in patients with drug refractory paroxysmal atrial fibrillation. Heart, 85, 48-52.
127. Stabile, G., De Simone, A., Turco, P., La Rocca, V., Nocerino, P., Astarita, C., et al. (2001). Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in atrial fibrillation. Journal of the American College of Cardiology, 37, 1639-1644.
128. Garg, A., Finneran, W., Mollerus, M., Birgersdotter-Green, U., Fujimura, O., Tone, L., et al. (1999). Right atrial compartmentalisation using radiofrequency catheter ablation for management of patients with refractory atrial fibrillation. Journal of Cardiovascular Electrophysiology, 10, 763-771.
129. Gerstenfeld, E. P., Guerra, P., Sparks, P. B., Hattori, K., & Lesh, M. D. (2001). Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers. Journal of Cardiovascular Electrophysiology, 12, 900-908.
130. Kanagaratnam, L., Tomassini, G., Schweikert, R., Pavia, S., Bash, D., Beheiry, S., et al. (2001). Empirical pulmonary vein isolation in patients with chronic atrial fibrillation using a three-dimensional nonfluoroscopic mapping system: Long-term follow-up. Pacing and Clinical Electrophysiology, 24, 1774-1779.
131. Friedman, P. A., Dijkman, B., Warman, E. N., Xia, H. A., Mehra, R., Stanton, M., et al. (2001). Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation, 104, 1023-1028.
132. D'Allonnes, G. R., Pavin, D., Leclerq, C., Ecke, J. E., Jauvert, G., Mabo, P., et al. (2000). Long-term effects of bi-atrial synchronous pacing to prevent drug refractory atrial tachyarrhythmia: A nine-year experience. Journal of Cardiovascular Electrophysiology, 11, 1081-1091.
133. Saksena, S., Lin, W. H., Prakash, A., & Filipecki, A. (2002). Long-term outcome of dual site right atrial pacing in patients with drug-refractory paroxysmal versus persistent or permanent atrial fibrillation. Journal of the American College of Cardiology, 39, 84A.
134. Prakash, A., Saksena, S., Krol, R. B., Filipecki, A., & Philip, G. (2002). Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 6, 165-172.
135. Saksena, S., & Madan, N. (2003). Hybrid therapy of atrial fibrillation: Algorithms and outcome. Journal of Interventional Cardiac Electrophysiology, 9, 235-247.
136. Plummer, C. J., & McComb, J. M. (2003). Detection of atrial fibrillation by permanent pacemakers: Observations from the STOP AF trial. Cardiac Electrophysiology Review, 7, 333-340.
137. Doshi, R. N., Daoud, E. G., Fellows, C., Turk, K., Duran, A., Hamdan, M. H., et al. (2005). Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (The PAVE Study). Journal of Cardiovascular Electrophysiology, 16(11), 1160-1165.